Relyea Zuckerberg Hanson LLC Vertex Pharmaceuticals Inc Transaction History
Relyea Zuckerberg Hanson LLC
- $847 Million
- Q2 2025
A detailed history of Relyea Zuckerberg Hanson LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 637 shares of VRTX stock, worth $298,854. This represents 0.03% of its overall portfolio holdings.
Number of Shares
637
Previous 762
16.4%
Holding current value
$298,854
Previous $369,000
23.31%
% of portfolio
0.03%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.82 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.53 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...